The main objective of these treatments is to focus on the system formed by programmed death 1 (PD-1) and its ligand PD-L1 (PD-1/PD-L1), a complex that participates in several aspects of the disease, such as the growth of the tumor, aggressiveness, and survival [95,96]. Here, CD274 is linked to neoplasm.